posted on 2019-06-21, 00:00authored byManuel Hitzenberger, Martin Zacharias
Knowledge of how
transition state inhibitors bind to γ-secretase
is of major importance for the design of new Alzheimer’s disease
therapies. On the basis of the known structure of γ-secretase
in complex with a fragment of the amyloid precursor protein, we generated
a structural model of γ-secretase in complex with the effective
L-685,458 transition state inhibitor. The predicted binding mode is
in excellent agreement with experimental data, mimicking all enzyme–substrate
interactions at the active site and forming the relevant transition
state geometry with the active site aspartate residues. The model
also indicates the possible location and nature of the amino acid
residues forming the proposed binding pockets S1′, S2′,
and S3′ near the active site that are occupied by chemical
groups of the inhibitor. In addition, we found that the stability
of the complex is very likely sensitive to the pH value. Comparative
simulations on the binding of L-685,458 and the epimer L682,679 allowed
us to explain the strongly reduced affinity of the epimer for γ-secretase.
The structural model could form a valuable basis for the design of
new or modified γ-secretase inhibitors.